Year-over-year earnings per share growth for the last twelve months: Heart Test Laboratories (HSCS)
Historical quarterly EPS growth demonstrates the impact of the commercial launch of AI systems, where 46.00 indicates the current level of profit dynamics. Heart Test Laboratories (HSCS) utilizes a fabless model, outsourcing the assembly of MyoVista to third-party contractors in the US. The company generates revenue by implementing intelligent ECG complexes in clinics, providing rapid diagnosis of cardiac pathologies for patients.
HSCS (Heart Test Labs): analytical breakdowns and indicator data
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Capital Heart Test Laboratories|HSCS - Long-Term Debt to Capital|Short-Term Debt to Equity Heart Test Laboratories|HSCS - Aggregate Debt Obligations|Debt to Book Value Heart Test Laboratories Inc.|HSCS - Amount of Long-Term Liabilities|Company Current Liabilities HeartSciences|Quick Liquidity Indicator heartsciences.com
- earnings and valuation multiples indicators:
HSCS - Profit After Payment of Taxes|Projected Future Earnings Heart Test Laboratories|HSCS - Market Cap to Earnings|Future Price to Earnings Heart Test Laboratories Inc.|HSCS - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Heart Test Laboratories Inc.|HSCS - Company profit before taxes, interest and amortization|Net earnings per share for the last 12 months HeartSciences|HSCS - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months heartsciences.com|HSCS - Earnings per share growth in current year|Earnings growth forecast for next year Heart Test Laboratories
Summary company analytics:HeartSciences, HSCS
Quarterly EPS growth on a daily basis filters out market noise, allowing investors to assess the real dynamics of net income per share without distortions from one-off transactions. When analyzing the quarterly earnings per share chart for Heart Test Laboratories (HSCS), one should look for a sustainable upward momentum that confirms the commercial efficiency of integrating MyoVista AI diagnostics into cardiology screening.
Competitor analysis for Heart Test Laboratories
A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Illumina Corp|Exact Sciences Inc. (EXAS) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth RVTY|BIO (bio-rad.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth NNNN (Anbio)|Sotera Health Corp (SHC) - Earnings per share growth in annualized terms for the last twelve months|QuidelOrtho Corp - Quarterly EPS earnings growth|OPK - Quarterly EPS earnings growth|caredx.com (CDNA) - Year-over-year earnings per share growth for the last twelve months|maravai.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months FLGT|LAB (Standard BioTools Inc) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CTKB (Cytek Bio)|OSUR (OraSure Corp) - Year-over-year earnings per one share growth for the last 12 months|Exagen - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months MDXH (mdxhealth.com)|Lucid Diagnostics - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Prenetics Global|imdxinc.com (IMDX) - Year-over-year earnings per share growth for the last twelve months|TRIB - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months PRPH|AIMD (ainos.com) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CODX (Co-Diagnostics)|BMRA (Biomerica Inc.) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Cardio Diagnostics Holdings CDIO|Onconetix Corporation - Year-over-year earnings per share growth for the last twelve months|Virax Biolabs Group - Quarterly EPS earnings growth|BJDX - Quarterly EPS earnings growth|AWH: Quarterly EPS earnings growth|AXDX (Accelerate Diagnostics Inc.) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months CENTOGENE|Earnings per share growth in annualized terms for the last twelve months Enzo ENZ|Year-over-year earnings per share growth for the last twelve months Fresh2 Group Limited (FRES)|GENE (gtglabs.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ME (23andMe)|Quarterly EPS earnings growth Psychemedics Corp. PMD
